antibody engineering, CAR T-cell therapy, cell signaling
A postdoctoral fellowship position is available in the Laboratory of Molecular Biology (LMB) at the National Cancer Institute (NCI) on the NIH main campus in Bethesda, Maryland. Our lab uses single domain antibodies to generate cancer therapeutics, including immunotoxins and chimeric antigen receptor (CAR) T cells [Feng et al. PNAS 2013; Gao et al. Hepatology 2014; Gao et al. Nature Communications 2015; Li et al. PNAS 2017]. We are interested in the role of glypicans (e.g., GPC2, GPC3) as co-receptors for Wnt signaling and the modulation of their activities in cancer, including liver cancer and pediatric cancers.
Candidates should have received a Ph.D. in cell and molecular biology, immunology or related disciplines. Experience in antibody engineering, animal models and/or immunotherapy is preferred. Excellent oral and written communication skills are needed. Recent Ph.D. graduates are welcome.
Please send an e-mail with your CV, the names of three references, and a cover letter briefly describing your research experience, interests, and career goals to the contact information below.
HHS, NIH, and NCI are Equal Opportunity Employers